Related Experiment Video
Updated: Dec 14, 2025

Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
[The mechanism underlying histone deacetylases regulating cardiac hypertrophy]
Lian Ren1, Xiu Shan Wu1, Yong Qing Li1
1State Key Lab of Development Biology of Freshwater Fish, Key Laboratory of the Ministry of Education, Heart Development Research Center, College of Life Sciences, Hunan Normal University, Changsha 410081, China.
Insights
Histone deacetylases (HDACs) regulate gene expression in cardiac hypertrophy. Understanding HDACs offers new therapeutic strategies for heart conditions and drug development.
Area of Science:
- Molecular Biology
- Cardiovascular Physiology
- Epigenetics
Background:
- Cardiac hypertrophy is a response to increased hemodynamic load.
- Gene expression changes are critical in cardiac hypertrophy.
- Histone acetylation, regulated by histone acetyltransferases (HAT) and histone deacetylases (HDACs), is a key epigenetic mechanism.
Purpose of the Study:
- To review research progress on histone deacetylases (HDACs) in cardiac hypertrophy.
- To elucidate the roles and molecular mechanisms of various HDACs in cardiac hypertrophy.
- To identify potential therapeutic targets for cardiac hypertrophy and heart failure.
Main Methods:
- Literature review of studies on HDACs and cardiac hypertrophy.
- Analysis of molecular mechanisms underlying HDAC regulation of gene expression.
- Synthesis of current understanding of HDACs' roles in physiological and pathological cardiac hypertrophy.
Main Results:
- HDACs are crucial regulators of gene expression during cardiac hypertrophy.
- Different HDACs participate in distinct pathways influencing cardiac remodeling.
- HDACs represent significant targets for therapeutic intervention in cardiac hypertrophy.
Conclusions:
- Elucidating specific HDAC functions provides insights into cardiac hypertrophy.
- Targeting HDACs offers potential for novel drug design for heart failure.
- Further research into HDACs can lead to tailored treatments for cardiac hypertrophy.
Abstract:
Cardiac hypertrophy is a compensatory response that occurs as a result of increased hemodynamic requirement in peripheral tissues. In the process of cardiac hypertrophy, the expression of different types of genes in different stages is transcriptionally regulated by multiple-level physiological and pathological signals. Histone acetylation, as the most extensive post-translational modification, is closely controlled by the antagonistic histone acetyltransferases (HAT) and histone deacetylases (HDACs). Recent studies have shown that HDACs, as a family of enzymes that inhibit transcription and contain highly conserved deacetylase domains, regulate gene expression during cardiac hypertrophy through a variety of pathways. In this review, we mainly summarize the research progress on histone deacetylase in cardiac hypertrophy. By elucidating the role and molecular mechanism of different HDACs in cardiac hypertrophy, it provides new ideas for the treatment of different types of cardiac hypertrophy and heart failure, and molecular targets for new drug design.
Related Concept Videos
Heart Failure II: Pathophysiology
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Histone Modification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pathophysiology of Heart Failure
Spreading of Chromatin Modifications
Writers
The writer...

